{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:43Z","timestamp":1788142903218,"version":"build-2803163510"},"reference-count":55,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"accepted":{"date-parts":[[2012,5,25]]},"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The anti-leukemic drugs, azathioprine and 6-mercaptopurine (6MP), are important in the treatment of inflammatory bowel disease but an alternative faster-acting, less-allergenic thiopurine, 6-thioguanine (6TG), can cause hepatic veno-occlusive disease\/sinusoidal obstructive syndrome (SOS). Understanding of SOS has been hindered by inability to ethically perform serial liver biopsies on patients and the lack of an animal model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Normal and C57Bl\/6 mice with specific genes altered to elucidate mechanisms responsible for 6TG-SOS, were gavaged daily for upto 28d with 6TG, 6MP or methylated metabolites. Animal survival was monitored and at sacrifice a histological score of SOS, haematology and liver biochemistry were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Only 6TG caused SOS, which was dose related. 6TG and to a lesser extent 6MP but not methylated metabolites were associated with dose-dependent haematopoietic toxicity. SOS was not detected with non-lethal doses of 6TG. SOS did not occur in hypoxanthine-phosphoribosyl transferase<jats:italic>-<\/jats:italic>deficient C57Bl\/6 mice, demonstrating that 6TG-SOS requires thioguanine nucleotides. Hepatic inflammation was characteristic of SOS, and C57Bl\/6 mice deficient in P- and E-selectins on the surface of vascular endothelial cells showed markedly reduced SOS, demonstrating a major role for leukocytes recruited from blood. Split dosing of 6TG markedly attenuated SOS but still effected immunosuppression and prevented spontaneous colitis in <jats:italic>Winnie<\/jats:italic> mice, which have a single nucleotide polymorphism mutation in <jats:italic>Muc2<\/jats:italic>.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This novel model provides clinically relevant insights into how 6TG induces SOS, and how this dangerous adverse drug reaction may be avoided by either inhibition of endothelial activation or simple changes to dosing regimens of 6TG, while still being effective treatment for colitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/gutjnl-2012-302274","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T21:15:52Z","timestamp":1341695752000},"page":"594-605","source":"Crossref","is-referenced-by-count":44,"title":["A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity"],"prefix":"10.1136","volume":"62","author":[{"given":"Iulia","family":"Oancea","sequence":"first","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"},{"name":"School of Medicine, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Wen","family":"Png","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajit","family":"Das","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Lourie","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"},{"name":"Mater Pathology, Mater Health Services, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid G","family":"Winkler","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, Mater Medical Research Institute, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaraman","family":"Eri","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H A","family":"Jinnah","sequence":"additional","affiliation":[{"name":"Department of Neurology, Human Genetics, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett C","family":"McWhinney","sequence":"additional","affiliation":[{"name":"Queensland Pathology Services, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Levesque","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, Mater Medical Research Institute, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"McGuckin","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"},{"name":"School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Duley","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"},{"name":"Mater Pathology, Mater Health Services, South Brisbane, Queensland, Australia"},{"name":"School of Pharmacy, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H J","family":"Florin","sequence":"additional","affiliation":[{"name":"IBD Team, Immunology Infection Inflammation Program, Mater Medical Research Institute, South Brisbane, Queensland, Australia"},{"name":"School of Medicine, University of Queensland, Brisbane, Queensland, Australia"},{"name":"Mater Health Services Department of Gastroenterology, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2012,7,7]]},"reference":[{"key":"2025090711413218000_62.4.594.1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000169061.52715.3e"},{"key":"2025090711413218000_62.4.594.2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316432"},{"key":"2025090711413218000_62.4.594.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03732.x"},{"key":"2025090711413218000_62.4.594.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.493"},{"key":"2025090711413218000_62.4.594.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.01.003"},{"key":"2025090711413218000_62.4.594.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492"},{"key":"2025090711413218000_62.4.594.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03788.x"},{"key":"2025090711413218000_62.4.594.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70140-5"},{"key":"2025090711413218000_62.4.594.9","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32420"},{"key":"2025090711413218000_62.4.594.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02583.x"},{"key":"2025090711413218000_62.4.594.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04221.x"},{"key":"2025090711413218000_62.4.594.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07413.x"},{"key":"2025090711413218000_62.4.594.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2003.00321.x"},{"key":"2025090711413218000_62.4.594.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01683.x"},{"key":"2025090711413218000_62.4.594.15","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200301000-00011"},{"key":"2025090711413218000_62.4.594.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-230656"},{"key":"2025090711413218000_62.4.594.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00938-7"},{"key":"2025090711413218000_62.4.594.18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110512"},{"key":"2025090711413218000_62.4.594.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.06.016"},{"key":"2025090711413218000_62.4.594.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2010.07.009"},{"key":"2025090711413218000_62.4.594.21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290615"},{"key":"2025090711413218000_62.4.594.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)01056-4"},{"key":"2025090711413218000_62.4.594.23","unstructured":"Strasser SI McDonald GB . Gastrointestinal and hepatic complications. In: Thomas ED Blume KG Forman SJ , eds. Haematopoietic Stem Cell Transplantation. Cambridge, MA: Blackwell Publishing, 1999:627\u201345."},{"key":"2025090711413218000_62.4.594.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050054"},{"key":"2025090711413218000_62.4.594.25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.281"},{"key":"2025090711413218000_62.4.594.26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem"},{"key":"2025090711413218000_62.4.594.27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.23.2001"},{"key":"2025090711413218000_62.4.594.28","unstructured":"Gibney MJ Lanham-New SA Cassidy A . Introduction to Human Nutrition. Oxford, UK: Blackwell Publishing, 2009:45."},{"key":"2025090711413218000_62.4.594.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.02.051"},{"key":"2025090711413218000_62.4.594.30","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.3748\/wjg.v11.i35.5540","article-title":"On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients","volume":"11","author":"de Boer","year":"2005","journal-title":"World J Gastroenterol"},{"key":"2025090711413218000_62.4.594.31","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20492"},{"key":"2025090711413218000_62.4.594.32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-267492"},{"key":"2025090711413218000_62.4.594.33","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.4.8.791"},{"key":"2025090711413218000_62.4.594.34","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.79.6.1196"},{"key":"2025090711413218000_62.4.594.35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0038-1657501","article-title":"Insights into selectin function from knockout mice","volume":"78","author":"Frenette","year":"1997","journal-title":"Thromb Haemost"},{"key":"2025090711413218000_62.4.594.36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-078204"},{"key":"2025090711413218000_62.4.594.37","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2010.74"},{"key":"2025090711413218000_62.4.594.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.10.007"},{"key":"2025090711413218000_62.4.594.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.07.004"},{"key":"2025090711413218000_62.4.594.40","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200103000-00013"},{"key":"2025090711413218000_62.4.594.41","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114363"},{"key":"2025090711413218000_62.4.594.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69558-5"},{"key":"2025090711413218000_62.4.594.43","unstructured":"Shann F . Drug Doses. Melbourne, Victoria: Royal Children's Hospital, Collective Publishing, 2006:3\u20137."},{"key":"2025090711413218000_62.4.594.44","first-page":"738","article-title":"A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine","volume":"34","author":"Tidd","year":"1974","journal-title":"Cancer Res"},{"key":"2025090711413218000_62.4.594.45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0026-895X(24)12548-5","article-title":"Human RnaseH-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxy-guanosine incorporation into DNA","volume":"56","author":"Krynetskaia","year":"1999","journal-title":"Mol Pharmacol"},{"key":"2025090711413218000_62.4.594.46","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.053157"},{"key":"2025090711413218000_62.4.594.47","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.63"},{"key":"2025090711413218000_62.4.594.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198304283081705"},{"key":"2025090711413218000_62.4.594.49","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(86)90067-6"},{"key":"2025090711413218000_62.4.594.50","doi-asserted-by":"publisher","DOI":"10.1007\/BF00487339"},{"key":"2025090711413218000_62.4.594.51","doi-asserted-by":"publisher","DOI":"10.1007\/BF00684949"},{"key":"2025090711413218000_62.4.594.52","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0021-9258(18)51867-6","article-title":"Reactions of ribonucleotide derivatives of purine analogues at the catalytic site of inosine 5'-phosphate dehydrogenase","volume":"238","author":"Hampton","year":"1963","journal-title":"J Biol Chem"},{"key":"2025090711413218000_62.4.594.53","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01391.x"},{"key":"2025090711413218000_62.4.594.54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2125.1983.tb02178.x","article-title":"Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia","volume":"16","author":"Lennard","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"2025090711413218000_62.4.594.55","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0022-3565(25)19953-9","article-title":"Mouse thiopurine methyltransferase pharmacogenetics: correlation of immunoreactive protein and enzymatic activity","volume":"252","author":"Hernandez","year":"1990","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2012-302274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:41:38Z","timestamp":1757270498000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2012-302274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,7]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,2,28]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1136\/gutjnl-2012-302274"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2012-302274","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,7]]}}}